SRA International Awarded $17.9 Million Task Order to Continue Support of The Cancer Genome Atlas by EON


More Info
									SRA International Awarded $17.9 Million Task
Order to Continue Support of The Cancer
Genome Atlas
Company Is Data Coordinating Center for The Cancer Genome Atlas Research Network

October 07, 2010 04:04 PM Eastern Daylight Time  

FAIRFAX, Va.--(EON: Enhanced Online News)--SRA International, Inc. (NYSE: SRX), a leading provider of
technology and strategic consulting services and solutions to government organizations and commercial clients, today
announced the award of a task order as a contractor to the National Institutes of Health (NIH) to continue
bioinformatics support of the Data Coordinating Center (DCC) for The Cancer Genome Atlas (TCGA). The new
award to SRA has a potential total dollar value of $17.9 million over five years, if all options are exercised.

A joint project of the National Cancer Institute and the National Human Genome Research Institute, TCGA is one
of the largest collaborative efforts ever attempted for the molecular characterization of tumors to improve our ability
to diagnose, treat and prevent cancer.

SRA has supported TCGA since its inception as a pilot in 2006. Based on the remarkable sets of multidimensional
data generated by the pilot, TCGA has expanded from a pilot on two cancers to a full program to study more than
20 types of cancer. The first 18 months of this task order are funded under the American Reinvestment and
Recovery Act, to help stimulate the economy through support of biomedical research.

"TCGA is among the most important projects at NIH,” said SRA Health Programs Vice President Paul Nedzbala.
"By leveraging our scientific and bioinformatics expertise, information technology, and innovation, SRA is proud to
support the expansion of this historic, groundbreaking program.” 

In addition to continued and expanded support of the DCC and the TCGA data portal, under the new award SRA
will develop a Data Algorithm Repository, as well as provide direct bioinformatics support to the TCGA Program
Office. As the DCC, SRA is responsible for collecting, transforming, disseminating, and conducting quality assurance
on all of the research study data generated by more than 60 organizations that make up the TCGA network of
laboratories, universities, cancer centers, and private companies, which all collaborate on the TCGA program. The
DCC efforts since the launch of the TCGA program in 2006 have included developing and supporting software that
controls data submission, reviewing the data for quality control, and development of an online data portal to share
the data with research and medical communities and the entire cancer community. SRA has also contributed to the
writing of several scientific papers characterizing brain and ovarian tumors.

About SRA International, Inc.

SRA and its subsidiaries are dedicated to solving complex problems of global significance for government
organizations and commercial clients serving the national security, civil government and global health markets.
Founded in 1978, the company and its subsidiaries have expertise in such areas as air surveillance and air traffic
management; contract research organization (CRO) services; cyber security; disaster response planning; enterprise
resource planning; environmental strategies; IT systems, infrastructure and managed services; learning technologies;
logistics; public health preparedness; public safety; strategic management consulting; systems engineering; and
wireless integration.
SRA and its subsidiaries employ more than 7,000 employees serving clients from its headquarters in Fairfax, Va.,
and offices around the world. For additional information on SRA, please visit

Any statements in this press release about future expectations, plans, and prospects for SRA, including
statements about the estimated value of the contract and work to be performed, and other statements
containing the words “estimates,” “believes,” “anticipates,” “plans, ” “expects,” “will,” and similar
expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation
Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking
statements. In addition, the forward-looking statements included in this press release represent our views as
of Oct. 7, 2010. We anticipate that subsequent events and developments will cause our views to
change.However, while we may elect to update these forward-looking statements at some point in the future,
we specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon
as representing our views as of any date subsequent to Oct. 7, 2010.

SRA International, Inc.
Sheila Blackwell
Vice President, Communications &
Public Affairs
Kelly Batalle
Director, Sector Communications


To top